These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22990724)

  • 21. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spastic paraparesis of obscure origin. A case-control study of HTLV-I positive and negative patients from Rio de Janeiro, Brazil.
    Araújo Ade C; Afonso CR; Schor D; Andrada-Serpa MJ
    J Neurol Sci; 1993 Jun; 116(2):165-9. PubMed ID: 8336163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease?
    Martins ML; Guimarães JC; Ribas JG; Romanelli LC; de Freitas Carneiro-Proietti AB
    J Neurovirol; 2017 Feb; 23(1):125-133. PubMed ID: 27678093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
    Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
    Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of CSF analysis for the differential diagnosis of HTLV-I associated myelopathy and multiple sclerosis.
    Puccioni-Sohler M; Kitze B; Felgenhauer K; Graef IT; Lange P; Novis S; Reiber H; Vaz B
    Arq Neuropsiquiatr; 1995 Dec; 53(4):760-5. PubMed ID: 8729769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human T-cell lymphotropic virus type I (HTLV-I) confirmed by PCR-Southern blot and sequencing analysis in a woman with tropical spastic paraparesis.
    Perandin F; Cariani A; Bonfanti C; Trainini L; Magoni M; Manca N
    Neurol Sci; 2006 Sep; 27(4):257-60. PubMed ID: 16998729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP): recent perspectives.
    Ijichi S; Osame M
    Intern Med; 1995 Aug; 34(8):713-21. PubMed ID: 8563108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y; Sato T
    Nihon Rinsho; 2013 May; 71(5):870-5. PubMed ID: 23777097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.
    Queiroz GAN; Mascarenhas REM; Vieillard V; Andrade RL; Galvão-Castro B; Grassi MFR
    BMC Infect Dis; 2019 May; 19(1):433. PubMed ID: 31101076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralizing antibodies against HTLV-I in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients and asymptomatic carriers.
    Minagawa H; Yoshida T; Itoyama Y; Mora CA; Albert P; Mori R
    Neurology; 1992 Nov; 42(11):2210-2. PubMed ID: 1436540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy.
    Oh U; Jacobson S
    Neurol Clin; 2008 Aug; 26(3):781-97, ix-x. PubMed ID: 18657726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence heterogeneity of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I-associated myelopathy.
    Kira J; Koyanagi Y; Yamada T; Itoyama Y; Tateishi J; Akizuki S; Kishikawa M; Baba E; Nakamura M; Suzuki J
    Ann Neurol; 1994 Aug; 36(2):149-56. PubMed ID: 8053650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HTLV-I-associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody.
    Grimaldi LM; Roos RP; Devare SG; Casey JM; Maruo Y; Hamada T; Tashiro K
    Ann Neurol; 1988 Dec; 24(6):727-31. PubMed ID: 3207356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.
    Morgan DJ; Caskey MF; Abbehusen C; Oliveira-Filho J; Araujo C; Porto AF; Santos SB; Orge GO; Joia MJ; Muniz AL; Siqueira I; Glesby MJ; Carvalho E
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1499-504. PubMed ID: 18160007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Araújo AQ; Afonso CR; Leite AC; Dultra SV
    Arq Neuropsiquiatr; 1993 Sep; 51(3):325-8. PubMed ID: 8297234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple sclerosis and HTLV-I associated myelopathy/tropical spastic paraparesis are two distinct clinical entities.
    Leon-S FE; Arimura K; Osame M
    Mult Scler; 1996 Sep; 2(2):88-90. PubMed ID: 9345386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Mendes GB; Kalil RS; Rosadas C; de Freitas MR; Puccioni-Sohler M
    Int J Infect Dis; 2014 Aug; 25():1-3. PubMed ID: 24815740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran.
    Shoeibi A; Rafatpanah H; Azarpazhooh A; Mokhber N; Hedayati-Moghaddam MR; Amiri A; Hashemi P; Foroghipour M; Hoseini RF; Bazarbachi A; Azarpazhooh MR
    Acta Neurol Belg; 2013 Dec; 113(4):427-33. PubMed ID: 23568138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.